Drawing for S

USPTO serial 88980606

S

Reviewed by CopyMark Law Group

Reg. 6310883Status 700Renewal
Filing date
Status date
Registration date
Mar 30, 2021
Examiner
SPARACINO, MARK V
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with S?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott W. Johnston

Scott W. Johnston MERCHANT & GOULD P.C.P.O. BOX 2910MINNEAPOLIS, MN 55423UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific or medical research use; Photoreactive chemical coating compositions for industrial, including medical, use; Chemicals for use in the manufacture of medical device coatings; Chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; Liquid preparation for use in stabilizing reagents employed in immunoassays; Chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; Chemicals, namely, a chemical solution for use in preserving analytical reagents for scientific and research use; photoreactive chemical coating compositions for general industrial use, and for use in the manufacture of medical devices and diagnostic test devices; Diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay components, namely, DNA assay substrates and reagents; Chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; Biopolymer based coatings for use in the manufacture of implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devicesACTIVE—
009Microarray slides for scientific, laboratory or medical research use; beads, membranes, plates and surfaces for scientific research use; customizable polymer surfaces that immobilize or attach target biomolecules to the surface while preventing adsorption of unwanted biomolecules to the surface, sold as an integral component of all the aforesaid goodsACTIVE—
010Medical devices and apparatus, namely, catheters and drug eluting balloon catheters; Medical devices, namely, stents that contain and deliver a wide range of pharmaceuticals; coatings for orthopedic implants, ocular implants and surgical implants comprised of artificial materials, sold as an integral part of the implants, for the delivery of a wide range of pharmaceuticals; Coatings sold as an integral component of medical stents and other implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices; Medical devices, namely, coronary stent systems; Medical devices, namely, angioplasty catheters; Medical devices, namely, medical device Access systems; Medical devices, namely, chronic total occlusion devices; Medical devices, namely, embolic protection device; Medical devices, namely, hemostasis introducer sheath; Medical devices, namely, interventional micro-catheterACTIVE—
040Surface treatment services for stabilizing proteins upon enzyme immunoassay product components of others; consulting about custom manufacturing medical and surgical devices; consulting in the field of medical devices related to manufacturing coaxial guide cathetersACTIVE—
042Research and development services in the field of chemical analysis tests and procedures; Research and development of new products for others in the fields of pharmaceuticals and medical and surgical devices; scientific and research consultation and product research in the fields of pharmaceuticals and medical and surgical devices; product development consultation in the fields of pharmaceuticals and medical and surgical devices; scientific and research consulting in the field of medical devices and medical device coatings and medical device drug delivery systems; scientific and research consulting in the fields of conducting medical pre-clinical studies and clinical trials; consulting in the field of quality control for medical devices and testing for quality control; Custom design of medical device coatings for others; Testing services for medical devices and medical device coatings; medical device testing for Durability, Shelf-life, aging studies process reproducibility, coating morphology consistency, Defect analysis, impurities, contaminants, drug release mechanisms; diagnostic services in the field of medical devices and coatings; Consulting in the field of medical devices related to design and development of coaxial guide catheterACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 30, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 30, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 24, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 23, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 19, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 19, 2021DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 10, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 21, 2021IUAFUSE AMENDMENT FILED—
Jan 21, 2021DRRRDIVISIONAL REQUEST RECEIVED—
Jan 21, 2021ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jan 21, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 18, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 16, 2020EX1GSOU EXTENSION 1 GRANTED—
Jul 16, 2020EXT1SOU EXTENSION 1 FILED—
Jul 16, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 17, 2019ALIEASSIGNED TO LIE—
Oct 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 10, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Oct 10, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 10, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 10, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 3, 2019DOCKASSIGNED TO EXAMINER—
Jul 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance